Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
增强体内病原体特异性记忆 CD8 T 细胞反应
基本信息
- 批准号:10471178
- 负责人:
- 金额:$ 58.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-12-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Abnormal CellAntibody ResponseAntigen-Presenting CellsAntigensAutophagocytosisB-LymphocytesBacteriaBindingCCL3 geneCCL4 geneCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCXCL9 geneCXCR3 geneCellsCellular biologyChemotaxisClonal ExpansionConstitutionContainmentCuesCytolysisEffector CellEventFundingGBP1 geneGene ExpressionGenesGeneticGenetic TranscriptionGoalsGrantGrowthHourI-antigenIRF4 geneITGAM geneImmuneImmune responseImmunityImmunizeImmunotherapyIn VitroIndividualInfectionInflammatoryInterferonsInterleukin-15Interleukin-18InvadedLaboratoriesLeadLeukocytesListeria monocytogenesLymphocyteMediatingMemoryMicrobeModelingMolecularMusNatural Killer CellsPhagocytesPlayPopulationProcessProductionProtein FamilyProteinsProviderPublic HealthReactive Oxygen SpeciesRegulationReportingRoleSignal TransductionSiteStudy modelsT cell responseT cell therapyT-LymphocyteTNF geneTestingTherapeuticUp-RegulationVaccinatedVaccinationVaccinesWorkXCL1 genebasechemokinecytokinedesignguanylateimaging approachimmunoregulationimprovedin vivointravital imagingloss of functionmicrobialmicrobicidemonocytemulti-photonneoplastic cellneutrophilnovelnovel strategiespathogenpathogenic microbeprogramsrecruitresponsetranscription factortumor
项目摘要
Abstract
Memory CD8+ T cells are essential adaptive effector cells of immune defenses because they are extremely
efficient at sensing intracellular pathogens and tumors. The chief effector feature of CD8+ T cells is their ability
to recognize and kill infected and “abnormal” cells but they also produce multiple effector cytokines and
chemokines that contribute to orchestrate protective immune responses. The cellular and molecular stepwise
mechanisms by which memory CD8+ T cells in vaccinated hosts are reactivated and mediate protection is not
well understood. Answering to this question has the potential to lead to novel strategies to harness or redirect
the power of CD8+ T cells to the benefit of the host in many therapeutic contexts. Over the years, using mice
immunized with the intracellular bacterium Listeria monocytogenes (Lm) as model, we have contributed to
show that during recall infection, vaccine-induced memory CD8+ T cells quickly sense sets of inflammatory
cytokines released from various antigen-presenting cells (APCs), which initiate a rapid effector program in the
memory CD8+ T cells. This includes notably the secretion of the potent immunomodulatory cytokine IFN which
further signals and activates microbicidal functions inside phagocytes, a necessary process for efficient
protection of vaccinated hosts. Yet, IFN is secreted to similar extent whether cognate T cell antigens are
present or not. Protection, however, is antigen-specific, suggesting that other factors distinct from memory
CD8+ T cell-derived IFN account for IFN-mediated protection. This proposal investigates these factors and
their regulation in the memory CD8+ T cells, which APCs provide cognate antigen to the memory CD8+ T cells
during recall infection and the dynamic interactions of memory CD8+ T cells and killer phagocytes using
cutting-edge intravital imaging approaches. Finally, we will also dissect the mechanisms of IFN-dependent
cell-autonomous defenses that are triggered inside activated phagocytes. We predict successful completion of
the proposed work will have a broad impact in the field of T cell biology and vaccines, and potentially important
therapeutic implications.
抽象的
记忆CD8+ T细胞是免疫防御的必不可少的自适应效应细胞
有效地感应细胞内病原体和肿瘤。 CD8+ T细胞的主要效应子特征是它们的能力
识别并杀死感染和“异常”细胞,但它们也会产生多种效应子细胞因子,并且
趋化因子有助于编排受保护的免疫复杂的趋化因子。细胞和分子逐步
接种宿主中的记忆CD8+ T细胞被重新激活而介导保护的机制不是
理解。回答这个问题有可能导致利用或重定向的新型策略
在许多治疗性情况下,CD8+ T细胞的功率对宿主的好处。多年来,使用小鼠
用细胞内细菌李斯特菌单核细胞增生(LM)作为模型进行免疫,我们为
表明在召回感染期间,疫苗诱导的记忆CD8+ T细胞迅速感知炎症的集合
从各种抗原呈递细胞(APC)释放的细胞因子,该细胞启动了快速效应程序
内存CD8+ T细胞。这特别包括有效的免疫调节细胞因子IFN的分泌
进一步的信号并激活吞噬细胞内的微生物功能,这是有效的必要过程
保护接种的宿主。然而,IFN分泌在类似的程度上
是否存在。但是,保护特定于抗原,表明其他因素与记忆不同
CD8+ T细胞衍生的IFN解释了IFN介导的保护。该提案调查了这些因素和
它们在存储器CD8+ T细胞中的调节,APC为记忆CD8+ T细胞提供同源抗原
在召回感染和记忆CD8+ T细胞和杀手吞噬细胞的动态相互作用期间
尖端的浸润成像方法。最后,我们还将剖析依赖IFN的机制
在活化的吞噬细胞内触发的细胞自主防御。我们预测成功完成
拟议的工作将对T细胞生物学和疫苗的领域产生广泛的影响,并可能重要
治疗意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregoire Stephane Lauvau其他文献
Gregoire Stephane Lauvau的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregoire Stephane Lauvau', 18)}}的其他基金
Early cellular sensing of blood stage Plasmodium Parasites by Innate Immune Cells
先天免疫细胞对血液阶段疟原虫寄生虫的早期细胞感知
- 批准号:
9292250 - 财政年份:2016
- 资助金额:
$ 58.31万 - 项目类别:
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
增强体内病原体特异性记忆 CD8 T 细胞反应
- 批准号:
10462204 - 财政年份:2012
- 资助金额:
$ 58.31万 - 项目类别:
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
增强体内病原体特异性记忆 CD8 T 细胞反应
- 批准号:
10655044 - 财政年份:2012
- 资助金额:
$ 58.31万 - 项目类别:
Selective Delivery of a novel bacterial adjuvant for multipurpose vaccination
用于多用途疫苗接种的新型细菌佐剂的选择性递送
- 批准号:
8418689 - 财政年份:2012
- 资助金额:
$ 58.31万 - 项目类别:
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
增强体内病原体特异性记忆 CD8 T 细胞反应
- 批准号:
9763417 - 财政年份:2012
- 资助金额:
$ 58.31万 - 项目类别:
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
增强体内病原体特异性记忆 CD8 T 细胞反应
- 批准号:
9132474 - 财政年份:2012
- 资助金额:
$ 58.31万 - 项目类别:
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
增强体内病原体特异性记忆 CD8 T 细胞反应
- 批准号:
8960918 - 财政年份:2012
- 资助金额:
$ 58.31万 - 项目类别:
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
增强体内病原体特异性记忆 CD8 T 细胞反应
- 批准号:
8593228 - 财政年份:2012
- 资助金额:
$ 58.31万 - 项目类别:
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
增强体内病原体特异性记忆 CD8 T 细胞反应
- 批准号:
8422357 - 财政年份:2012
- 资助金额:
$ 58.31万 - 项目类别:
相似国自然基金
B7H4-LILRB4信号调控B细胞代谢重编程机制在同种抗体产生及防治AMR中的作用
- 批准号:82371792
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
抗变构/单体形式的C反应蛋白关键抗原表位199-206抗体在狼疮性肾炎小管间质病变中的作用机制及其靶向治疗研究
- 批准号:82300829
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TSC1对滤泡辅助性T细胞在抗体介导的排斥反应中的调控作用及其机制研究
- 批准号:82370760
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
NK细胞靶向微泡超声分子成像评价抗体介导排斥反应的研究
- 批准号:82302225
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗BP180抗体活化基底层角质形成细胞中Fn14-TRAF2-ZFP36轴促进大疱性类天疱疮炎症反应的机制探究
- 批准号:82373476
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)
临床前和已确诊狼疮分子分析转化中心 (COMPEL)
- 批准号:
9766075 - 财政年份:2017
- 资助金额:
$ 58.31万 - 项目类别:
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)
临床前和已确诊狼疮分子分析转化中心 (COMPEL)
- 批准号:
9370747 - 财政年份:2017
- 资助金额:
$ 58.31万 - 项目类别:
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)
临床前和已确诊狼疮分子分析转化中心 (COMPEL)
- 批准号:
10004495 - 财政年份:2017
- 资助金额:
$ 58.31万 - 项目类别:
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)
临床前和已确诊狼疮分子分析转化中心 (COMPEL)
- 批准号:
10249207 - 财政年份:2017
- 资助金额:
$ 58.31万 - 项目类别:
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
增强体内病原体特异性记忆 CD8 T 细胞反应
- 批准号:
10462204 - 财政年份:2012
- 资助金额:
$ 58.31万 - 项目类别: